Data from Cistrome_DB also showed higher USF2 binding scores to oncogenic metabolic hubs, but these scores were minimal to none for tumor suppressor metabolic hubs in bladder cancer (Figure 5D) suggesting USF2 as key transcription factor to regulate oncogenic metabolic hubs in bladder cancer. The gene discussed is USF2; the disease is urinary bladder cancer.